Search jobs
22-Apr-2021
Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research
Focused on enabling more selective approaches for certain extracorporeal blood purification (EBP) therapies
Led by Baxter’s renowned research and development team in Hechingen, Germany
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF). With the grant, Baxter will lead an initiative aiming to create a new technology platform enhancing the ability to target selective removal of pathogenic substances during certain extracorporeal (outside the body) blood purification (EBP) therapies. The grant provides €1.5 million in funding over three years to Baxter and its research partners through the BMBF’s “Biomaterials Platform: Mat2MedTech” program.